U.S Class(es): 006, 018, 044, 046, 051, 052
Class Status: Active
Name | Novartis Pharma AG,; Trademark Departmen |
---|---|
Address | Postfach CH-4002 Basel SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
Jun-07-2018 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM | |
Jun-11-2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Jun-12-2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | NWOSI | |
Jun-16-2018 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Jun-19-2018 | ASSIGNED TO EXAMINER | DOCKD | |
Jun-19-2018 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Jul-04-2018 | NOTICE OF PUBLICATION | NPUBO | |
Jul-24-2018 | PUBLISHED FOR OPPOSITION | PUBOA | |
Oct-09-2018 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Nov-08-2018 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Nov-28-2018 | FINAL DISPOSITION PROCESSED | FIMPP | |
Nov-28-2018 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Dec-20-2018 | CORRECTION TRANSACTION RECEIVED FROM IB | CRCVM | |
Dec-20-2018 | NOTIFICATION PROCESSED BY IB | GPNXP | |
May-17-2019 | REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED | RCIII | |
May-21-2019 | ASSIGNED TO PETITION STAFF | APETA | |
May-31-2019 | REG. CANCELLED - RESTORED TO PENDENCY | CRTPC | |
Jul-09-2019 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | CREVI | |
Jul-24-2019 | NOTICE OF PUBLICATION | NPUBO | |
Jul-24-2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | OP2RP | |
Jul-24-2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
Aug-13-2019 | PUBLISHED FOR OPPOSITION | PUBOA | |
Aug-23-2019 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Oct-29-2019 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Nov-28-2019 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Jan-02-2020 | FINAL DISPOSITION PROCESSED | FIMPP | |
Jan-03-2020 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Feb-14-2020 | NOTIFICATION PROCESSED BY IB | GPNXP |